Egypt Pharmaceutical Market

Egypt Pharmaceutical Market Overview: 

The Egypt pharmaceutical market size reached US$ 5.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.0 Billion by 2032, exhibiting a growth rate (CAGR) of 9.20% during 2024-2032. There are various factors that are driving the market, which include the growing geriatric population, increasing number of pharma exhibitions, favorable government initiatives, and rising cases of numerous chronic diseases.

Egypt Pharmaceutical Market Trends:

Rising Geriatric Population

There is a rise in the need for a wide variety of pharmaceuticals among elderly individuals because they are more prone to chronic diseases such as hypertension, diabetes, arthritis, cardiovascular diseases, and respiratory conditions. Elderly patients often require multiple medications simultaneously to manage various health conditions. In addition, the increasing emphasis on preventive healthcare among individuals is contributing to the market growth. There is a rise in the focus on vaccinations, vitamins, and supplements to maintain health and prevent diseases. This contributes to the increased demand for diverse pharmaceutical products. Besides this, there is a rise in the need for personalized and customized treatment plans for elderly patients, who often have complex health profiles, necessitating a broader range of pharmaceutical options to cater to their specific needs. The number of persons aged 60+ is anticipated to more than double between 2020-2050 from 8.4 million to 22 million in Egypt, as claimed by the United Nations Population Fund (UNFPA).

Increasing Number of Pharma Exhibitions

On 4 September 2023, Dozens of Chinese pharmaceutical companies participated in Pharmaconex 2023, an international pharma exhibition held in Egypt's capital Cairo, in order to explore business opportunities in Egypt and the rest of Africa and the Middle East. The three-day exhibition gathered pharmaceutical companies from countries including Egypt, China, India, the United States, Italy, France, Belgium, Saudi Arabia, and the United Arab Emirates. Furthermore, pharmaceutical exhibitions provide a platform for industry professionals to network, exchange ideas, and forge partnerships. This facilitates collaboration between local and international companies, leading to business expansion and growth. Exhibitions serve as a stage for companies to showcase their latest products, technologies, and innovations. This exposure helps in promoting new pharmaceutical products and attracting potential buyers and investors. Moreover, these events offer valuable insights into market trends, consumer preferences, and emerging technologies. Participants can gain a better understanding of the market landscape, enabling them to make informed business decisions.

Egypt Pharmaceutical Market News:

• 19 March 2024: Egypt-based healthtech Pharmacy Marts raised a six-figure bridge round, led by Acasia Ventures. Pharmacy Marts aims to digitize the pharmaceutical sector’s supply chain to improve patient access to medication.
• 4 December 2023: Valu, MENA’s leading universal financial technology powerhouse, and GSK, a science-led global healthcare company, announced a partnership that aims at providing flexible financing solutions for a range of GSK’s vaccines available at a wide range of pharmacies across Egypt. By introducing innovative financing options, the collaboration endeavors to make the purchase of GSK’s vaccines more attainable for a wider demographic, thereby positively impacting the healthcare landscape in Egypt. In this collaboration, Valu and GSK focus on creating a more inclusive and equitable healthcare ecosystem, aligning with their shared vision of advancing public health and well-being in Egypt.
   

Egypt Pharmaceutical Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on type and nature.

Type Insights:

• Pharmaceutical Drugs
  • Cardiovascular Drugs
  • Dermatology Drugs
  • Gastrointestinal Drugs
  • Genito-Urinary Drugs
  • Hematology Drugs
  • Anti-Infective Drugs
  • Metabolic Disorder Drugs
  • Musculoskeletal Disorder Drugs
  • Central Nervous System Drugs
  • Oncology Drugs
  • Ophthalmology Drugs
  • Respiratory Diseases Drugs
• Biologics
  • Monoclonal Antibodies (MAbS)
  • Therapeutic Proteins
  • Vaccines
     

The report has provided a detailed breakup and analysis of the market based on the type. This includes pharmaceutical drugs (cardiovascular drugs, dermatology drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs, anti-infective drugs, metabolic disorder drugs, musculoskeletal disorder drugs, central nervous system drugs, oncology drugs, ophthalmology drugs, and respiratory diseases drugs) and biologics (monoclonal antibodies (MAbS), therapeutic proteins, and vaccines).

Nature Insights:

• Organic
• Conventional
   

A detailed breakup and analysis of the market based on the nature have also been provided in the report. This includes organic and conventional.

Regional Insights:

• Greater Cairo
• Alexandria
• Suez Canal
• Delta
• Others
   

The report has also provided a comprehensive analysis of all the major regional markets, which include Greater Cairo, Alexandria, Suez Canal, Delta, and Others.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Egypt Pharmaceutical Market Report Coverage:

Key Questions Answered in This Report:

• How has the Egypt pharmaceutical market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Egypt pharmaceutical market?
• What is the breakup of the Egypt pharmaceutical market on the basis of type?
• What is the breakup of the Egypt pharmaceutical market on the basis of nature?
• What are the various stages in the value chain of the Egypt pharmaceutical market? 
• What are the key driving factors and challenges in the Egypt pharmaceutical?
• What is the structure of the Egypt pharmaceutical market and who are the key players?
• What is the degree of competition in the Egypt pharmaceutical market?

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Egypt pharmaceutical market from 2018-2032.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Egypt pharmaceutical market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Egypt pharmaceutical industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.